EUVIMEDEUVIMED entdecken
Crossref

Integrated prognostic value of MRD and cytogenetics in adolescent and adult B‐cell acute lymphoblastic leukaemia

Jiayan Gu, Jinghan Wang, Lin Liu iD, Yi Zhang, Parnia Ghanad, Maryam Maleki Goli, Chenhui Bao, Jie Jin iD, Hongyan Tong iD

British Journal of Haematology · 2025

DOI: 10.1111/bjh.70281 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Jiayan Gu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The First Affiliated Hospital, College of Medicine, Institute of Hematology, Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province Grant/AwardNumber : LMS25H080003.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

B‐cell acute lymphoblastic leukaemia (B‐ALL) in adolescents and adults remains challenging due to high relapse rates and suboptimal outcomes. Although minimal residual disease (MRD) and cytogenetic risk classification are independent prognostic indicators for B‐ALL in adolescents and adults, their combined utility remains under explored. This retrospective study analysed 609 adolescent and adult patients with B‐ALL to evaluate the integrated prognostic value of MRD at end of induction (MRD1) and after first consolidation (MRD2), combined with cytogenetic risk stratification (standard risk [SR] vs. poor risk [PR]). Although cytogenetic risk alone was not an independent prognostic factor, MRD positivity at either time point significantly predicted inferior 5‐year RFS and OS in PR patients. Allogeneic haematopoietic stem cell transplantation (allo‐HSCT) improved outcomes overall; however, PR patients with MRD2 positivity remained at high risk of relapse post‐transplant. Multivariate analysis identified MRD1 and MRD2 as independent predictors of both relapse (RFS HR = 2.048) and mortality (OS HR = 1.979) in PR patients (all p < 0.01). These results demonstrate that combining MRD assessment with cytogenetic risk improves risk stratification, precisely identifying poor‐risk patients with persistent MRD who may benefit from treatment intensification, including novel strategies post‐transplant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precursor B-Cell Lymphoblastic Leukemia-LymphomaHumansNeoplasm, ResidualAdolescentAdultFemaleMalePrognosisRetrospective StudiesYoung AdultHematopoietic Stem Cell TransplantationMiddle AgedCytogenetic Analysis

Stichwörter der Autor:innen

B‐cell acute lymphoblastic leukaemiaadolescent and adultcytogenetic risk classificationminimal residual disease

Autor:innen und Institutionen

  • Department of Hematology, The First Affiliated Hospital, College of Medicine, Institute of Hematology, Zhejiang University, Hangzhou, China.
  • Key Laboratory of Hematologic Malignancies, Diagnosis and Treatment, Hangzhou, Zhejiang, China.
  • Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, China.
  • Zhejiang University Cancer Center, Zhejiang University, Hangzhou, China.
  • College of Medicine, Zhejiang University, Hangzhou, China.

ORCID-Profile: Lin Liu, Jie Jin, Hongyan Tong

Förderung

  • Natural Science Foundation of Zhejiang Province Grant/AwardNumber : LMS25H080003

Zitieren

APA

Gu, J., Wang, J., Liu, L., Zhang, Y., Ghanad, P., Goli, M. M., Bao, C., Jin, J., & Tong, H. (2025). Integrated prognostic value of MRD and cytogenetics in adolescent and adult B‐cell acute lymphoblastic leukaemia. British Journal of Haematology. https://doi.org/10.1111/bjh.70281

Vancouver

Gu J, Wang J, Liu L, Zhang Y, Ghanad P, Goli MM, et al. Integrated prognostic value of MRD and cytogenetics in adolescent and adult B‐cell acute lymphoblastic leukaemia. British Journal of Haematology. 2025. doi:10.1111/bjh.70281

BibTeX
@article{Gu2025,
  author = {Gu, Jiayan and Wang, Jinghan and Liu, Lin and Zhang, Yi and Ghanad, Parnia and Goli, Maryam Maleki and Bao, Chenhui and Jin, Jie and Tong, Hongyan},
  title = {Integrated prognostic value of MRD and cytogenetics in adolescent and adult B‐cell acute lymphoblastic leukaemia},
  journal = {British Journal of Haematology},
  year = {2025},
  doi = {10.1111/bjh.70281}
}
Kostenlos starten →